Company intelligence / Profile preview
INTENT Biologics
San Francisco, California, United Statesintent.bio ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Intent is a biotechnology company building a platform for the intentional design of biologics, moving beyond the stochastic nature of traditional drug discovery. By integrating high-throughput experimental data with advanced computational models, the company engineers proteins and antibodies with optimized therapeutic and biophysical properties. Intent's approach aims to create next-generation medicines for complex diseases in immunology and oncology with improved potency and safety profiles. The company is backed by leading life science investors and is led by a team with deep expertise in protein engineering and drug development.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Monoclonal antibodyRecombinant proteinBiologicProtein
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on INTENT Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on INTENT Biologics.